Follow us:
+91 44 6746 8080 info@caplinsteriles.net
Menu
  • Home
  • About Us
    • Strength
    • Milestones
    • Board of Directors
    • Plant Leadership Team
    • Partnership
    • Gallery
  • News
  • Caplin Cares
  • Policy
    • Quality Policy
    • Environmental Policy
  • Careers
  • Contact

Caplin point announces FDA approval for ketrolac tromethamine injection 30mg/ml

August 7, 2020
| No Comments
20.09.2017Download
Categories: News

Post navigation

← Caplin point gets EIR for USFDA for sterile injectable site.
Caplin Steriles signs license & supply agreement with baxter healthcare corporation. →
About Us

Caplin Steriles Limited, a subsidiary of fast growing pharmaceutical company Caplin Point Laboratories Ltd, specifically targeted towards regulated markets for Injectables and Ophthalmics.

USEFUL LINKS
  • Home
  • About Us
    • Strength
    • Milestones
    • Board of Directors
    • Plant Leadership Team
    • Partnership
    • Gallery
  • News
  • Caplin Cares
  • Policy
    • Quality Policy
    • Environmental Policy
  • Careers
  • Contact
Latest Posts
Caplin Steriles Gets USFDA Approval for Milrinone lactate Injection April 19, 2021
BT Business Leaders of TN: Manufacturing, electronics, SaaS can make India $5 trillion economy, say experts February 16, 2021
CAPLIN STERILES GETS USFDA APPROVAL FOR ARGATROBAN INJECTION January 22, 2021
CAPLIN STERILES ENTERS INTO A STRATEGIC PARTNERSHIP WITH JAMP PHARMA GROUP FOR CANADA January 18, 2021
Get in touch

+91 44 2496 8000

info@caplinsteriles.net

Caplin Steriles Ltd.
1st Floor, Ashvich Towers,
No 3, Developed Plots Industrial Estate,
Perungudi, Chennai 600096.
Tamil Nadu,
India.

© 2021 Caplin Steriles Ltd . All Rights Reserved
Powered by Ashvich Infotek Pvt Ltd.